Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Maokangyuan Biotech is a specialized biotechnology company focused on the research, development, and large-scale production of animal-derived biochemical APIs. Based in the Benxi High-tech Zone, also known as China's Medicine Capital, the company primarily produces heparin-related products, including Heparin Sodium and Enoxaparin Sodium. Its facilities are designed to meet international GMP standards, serving as a key supplier for pharmaceutical companies involved in anticoagulation and cardiovascular therapies. Beyond heparin, the company explores other biochemical extractions and purification technologies to expand its portfolio of life science raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Maokangyuan Biotech.